MPT on NYSE

Medical Properties Trust

Logo: The logo may be obtained from Medical Properties Trust ., Non-free logo, via Wikipedia5

American real estate investment trust

Medical Properties Trust, Inc. (MPT), headquartered in Birmingham, Alabama, is a real estate investment trust that invests in healthcare facilities. As of December 31, 2025, the company owned interests in 384 facilities with a total of 39,000 beds in the United States (161 properties), United Kingdom (92 properties), Germany (85 properties), Switzerland (19 properties), Spain (9 properties), Italy (8 properties), Finland (4 properties), Colombia (4 properties), and Portugal (2 properties).3 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 20, 2026.

Overview

Compare with Cousins Properties, American Campus Communities or SL Green Realty, or pick any stock.

  • TickerMPT on NYSE1
  • Industryreal estate investment trust1
  • HeadquartersBirmingham1
  • Websitewww.medicalpropertiestrust.com
  • Business address10500 Liberty Parkway, Birmingham, Al6
  • Filer categoryLarge accelerated filer6
  • Legal formStock Corporation4
  • LEI254900U6E39J1MQCCY144
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE CORPORATION TRUST INCORPORATED, 21093 Lutherville Timonium, United States4
  • Registered withBusiness Services (Maryland Department of Assessments and Taxation), D075501064

Medical Properties Trust, Inc. (MPT), headquartered in Birmingham, Alabama, is a real estate investment trust that invests in healthcare facilities.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-28.5%Net margin40
-2.4%Revenue growth, 202540
-6.0%Return on equity40
2.11×Debt to equity40

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue9¢$90.3M
  • Other costs34¢$332.7M
  • Interest53¢$510.4M
  • Income tax4¢$38.6M

Out of $972.0M in revenue.40 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks10¢$23.4M
  • Kept or used elsewhere90¢$207.3M

Out of $230.8M of cash from operations.40

Financial statements

Revenue4142434440$972.0M in 2025+14% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $854.2M$854.2M20192020: $1.2B$1.2B2020+46%2021: $1.5B$1.5B2021+24%2022: $1.5B$1.5B2022−0%2023: $871.8M$871.8M2023−43%2024: $995.5M$995.5M2024+14%2025: $972.0M$972.0M2025−2%
Net income4142434440-$277.0M in 2025
-$3.0B-$2.0B-$1.0B0$1.0B2019: $374.7M$374.7M20192020: $431.4M$431.4M2020+15%2021: $656.0M$656.0M2021+52%2022: $902.6M$902.6M2022+38%2023: -$556.5M-$556.5M20232024: -$2.4B-$2.4B2024+333%2025: -$277.0M-$277.0M2025−89%

Every line of the income statement as filed: the last 3 fiscal years, latest first.40

Period ending2025-12-312024-12-312023-12-31
Rent billed$736.5M$719.7M$803.4M
Straight-line rent$152.2M$163.4M-$127.9M
Income from financing leases$39.7M$63.7M$127.1M
Interest and other income$43.6M$48.7M$69.2M
Total revenues$972.0M$995.5M$871.8M
Interest$510.4M$417.8M$411.2M
Real estate depreciation and amortization$265.4M$447.7M$603.4M
Property-related$36.4M$27.3M$41.6M
General and administrative$130.4M$133.8M$145.6M
Total expenses$942.6M$1.0B$1.2B
Gain (loss) on sale of real estate$5.5M$478.7M-$1.8M
Real estate and other impairment charges, net-$193.9M-$1.8B-$376.9M
Earnings (loss) from equity interests$97.9M-$366.6M$14.0M
Debt refinancing and unutilized financing (costs) benefit-$3.6M-$4.3M$285.0K
Other (including fair value adjustments on securities)-$172.6M-$615.6M$7.6M
Total other expense-$266.7M-$2.3B-$356.9M
Loss before income tax-$237.3M-$2.4B-$686.8M
Income tax (expense) benefit-$38.6M-$44.1M$130.7M
Net (loss) income-$275.9M-$2.4B-$556.1M
Net income attributable to non-controlling interests-$1.1M-$2.0M-$384.0K
Net loss attributable to MPT common stockholders-$277.0M-$2.4B-$556.5M
Net loss attributable to MPT common stockholders (Operating Partnership partners), basic-$0.46-$4.02-$0.93
Net loss attributable to MPT common stockholders (Operating Partnership partners), diluted-$0.46-$4.02-$0.93
Weighted average shares (units) outstanding basic600.9M shares600.2M shares598.5M shares
Weighted average shares (units) outstanding diluted600.9M shares600.2M shares598.5M shares

Compare Medical Properties Trust with another company

Corporate structure

Medical Properties Trust sits at the top of its group. 472 entities, 7 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Medical Properties Trust

  • VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Medical Properties Trust, latest Apr 29, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Medical Properties Trust, latest Mar 27, 2026 (6 filings since Feb 10, 2022)
  • Zhengxu He Filed SCHEDULE 13G/A on Medical Properties Trust, latest Jan 6, 2026 (3 filings since Oct 24, 2024)
  • State Street Corporation Filed SCHEDULE 13G on Medical Properties Trust, latest Nov 10, 2025 (4 filings since Feb 11, 2022)
  • BlackRock Filed SCHEDULE 13G/A on Medical Properties Trust, latest Oct 17, 2025 (3 filings since Oct 23, 2024)
  • Daniel Yet Filed SCHEDULE 13G/A on Medical Properties Trust, latest Feb 12, 2025 (3 filings since Sep 19, 2024)
  • Cohen & Steers Filed SC 13G/A on Medical Properties Trust, latest Feb 14, 2022
  • Wellington Management Company Filed SC 13G/A on Medical Properties Trust, latest Feb 4, 2022

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Medical Properties Trust reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$1.8B40 Dec 31, 2025$1.6B40 Dec 31, 2024+11.3%
Buildings and improvements$9.5B40 Dec 31, 2025$8.8B40 Dec 31, 2024+7.9%
Finance-lease assets$1.6M44 Dec 31, 2024$1.7M44 Dec 31, 2023−3.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$540.9M40 Dec 31, 2025$332.3M40 Dec 31, 2024+62.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Accumulated amortization$600.0M40 Dec 31, 2025$600.0M40 Dec 31, 20240%

Properties, in its own words

At December 31, 2025, our portfolio (including properties in our five real estate joint ventures) consisted of 384 properties (including properties under construction or in the form of a first lien mortgage loan) operated by 52 different operators. Our vacant facilities represent less than 1% of total assets at December 31, 2025.

TotalProperties · Total 2025Revenues · TotalAssets(A)

The rest of Item 2

(Dollars in thousands)

United States:

Alabama · 2 · 791 · 6,162

Arizona · 8 · 37,519 · 328,873

Arkansas · 1 · 10,582 · 65,030

California · 17 · 69,157 · 977,890

Colorado · 3 · 10,746 · 102,549

Connecticut · 3 · 60 · 41,414

Florida · 6 · 21,696 · 834,940 · (B)

Idaho · 6 · 42,180 · 299,826

Indiana · 4 · 7,148 · 58,522

Iowa · 1 · 5,396 · 44,374

Kansas · 9 · 15,982 · 208,893 · (B)

Kentucky · 1 · 10,288 · 53,080

Louisiana · 5 · 6,060 · 106,713

Massachusetts · 2 · 436 · 244,824 · (D)

Michigan · 1 · 3,521 · 13,038

Missouri · 4 · 23,986 · 117,424

Montana · 1 · 2,049 · 19,134

New Jersey · 2 · 21,520 · 142,121

New Mexico · 2 · 5,271 · 50,519

North Carolina · 1 · 3,163 · 30,027

Ohio · 9 · 25,910 · 330,189 · (B)

Oklahoma · 1 · 7,082 · 6,855

Oregon · 1 · 12,588 · 80,539

Pennsylvania · 7 · 31,450 · 304,372

South Carolina · 5 · 17,174 · 123,512

Texas · 44 · 100,839 · 1,427,391 · (C)

Utah · 7 · 4,288 · 193,752 · (E)

Virginia · 2 · 2,940 · 15,728

Washington · 2 · 4,319 · 35,334

Wisconsin · 1 · 3,703 · 27,266

Wyoming · 3 · 10,034 · 89,174

Other assets · — · — · 1,072,900

Total United States · 161 · 517,878 · 7,452,365

International:

Colombia · 4 · 6,216 · 147,620

Germany · 85 · 42,686 · 751,806 · (E)

Italy · 8 · — · 86,091 · (E)

Portugal · 2 · 3,748 · 50,205

Spain · 9 · 12,599 · 302,323 · (D)(E)

Switzerland · 19 · 2,877 · 873,703 · (E)

United Kingdom · 92 · 373,279 · 4,184,188

Finland · 4 · 12,739 · 220,813

Other assets · — · — · 932,661

Total International · 223 · 454,144 · 7,549,410

Total · 384 · 972,022 · 15,001,775

Represents total assets at December 31, 2025.

Includes a facility that was vacant at December 31, 2025.

Includes a development project still under construction and facilities that were vacant at December 31, 2025.

Includes development project(s) still under construction at December 31, 2025.

For Germany, the U.S., Switzerland, Spain, and Italy, we own properties through five real estate joint venture arrangements and our share of revenues from these joint ventures is reflected in the "Earnings (loss) from equity investments" line of our consolidated statements of net income. However, the table below shows revenues earned from these joint venture arrangements:

TotalProperties · Total 2025 Revenues

(Dollars in thousands)

Germany · 71 · 70,614

U.S. · 5 · 24,733

Switzerland · 19 · 61,077

Spain · 2 · 7,463

Italy · 8 · 7,111

Total · 105 · 170,998

A breakout of our facilities at December 31, 2025 based on property type is as follows:

Number ofProperties · TotalSquareFootage · TotalLicensedBeds(A)

General acute care hospitals · 168 · 27,501,398 · 17,184

Behavioral health facilities · 68 · 3,067,544 · 4,238

Post acute care facilities · 128 · 13,788,289 · 17,109

FSERs · 20 · 170,642 · —

384 · 44,527,873 · 38,531

Reflects all properties, including those that are part of real estate joint ventures, except for our facilities that are under development.

The following table shows lease and loan expirations, assuming that none of the tenants/borrowers exercise any of their renewal options (dollars in thousands):

Total Lease and Loan Portfolio(1) · TotalLeases/Loans(2) · AnnualizedBaseRent/Interest(3) · % of TotalAnnualizedBaseRent/Interest · TotalSquareFootage · TotalLicensedBeds

2026 · 1 · 228 · — · 7,040 · —

2027 · 1 · 3,681 · 0.3 · 107,849 · 13

2028 · 7 · 17,746 · 1.5 · 1,946,588 · 559

2029 · 4 · 16,112 · 1.4 · 775,575 · 527

2030 · 10 · 7,128 · 0.6 · 309,615 · 84

2031 · 4 · 3,852 · 0.3 · 133,505 · 123

2032 · 21 · 60,495 · 5.2 · 1,067,663 · 743

2033 · 5 · 6,201 · 0.6 · 85,477 · 24

2034 · 8 · 62,889 · 5.5 · 1,968,674 · 1,345

2035 · 7 · 25,516 · 2.2 · 750,199 · 983

Thereafter · 301 · 950,848 · 82.4 · 34,793,831 · 33,402

Total · 369 · 1,154,696 · 100.0 · 41,946,016 · 37,803

Schedule includes leases and mortgage loans and related terms as of December 31, 2025.

Reflects all properties, including those that are part of real estate joint ventures, except vacant properties (less than 1% of total assets), facilities that are under development, and transitioning properties.

Represents base rent/interest income contractually owed per the lease/loan agreements on an annualized basis as of period end (including foreign currency exchange rates) but does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues), or any reserves or write-offs.

Item 2 of the 10-K filed Feb 26, 2026.49

The story

2003–2014

The company was founded by Edward K. Aldag, Jr. and others on August 27, 2003, as successor to a previous venture, Medical Properties Trust, LLC, which was formed in Maryland in December 2002.

In July 2005, MPT became a public company via an initial public offering.

In late 2005, the company completed one of its first developments: Town & Country Hospital in Houston, Texas, at cost of $65 million; it was sold in 2007 to Memorial Hermann Health System for $70 million.

In 2012, MPT announced a $400 million deal to acquire a 49% stake in Albuquerque, New Mexico-based Ernest Health, as well as the underlying real estate of the health system's 16 rehabilitation and long-term acute care facilities in nine states. It sold the interest in May 2018.

In December 2013, MPT expanded internationally for the first time with the real estate purchase of eleven rehabilitation hospitals in Germany, operated by RHM Klinik- und Altenheimbetriebe (RHM), for €184 million.

In August 2014, the company acquired its first hospital in the United Kingdom, Circle Bath in Peasedown St John, for £28.3 million.

2015–2019

In July 2015, MPT purchased Capella Healthcare, operating in Tennessee, from GTCR for $900 million–$300 million for a portion of its operations, and $600 million for its real estate in a leaseback arrangement.

One year later, it sold its stake in Capella's operations to Apollo Global Management for $390 million; it was merged with RegionalCare. MPT continued to own the real estate.

Read the full text

In October 2016, MPT finalized the leaseback of five properties of Steward Health Care, a health system in Massachusetts based on a $1.25 billion asset value. In addition to properties, MPT acquired a 5% stake in Steward for $50 million.

In February 2017, MPT purchased properties from Steward for $301 million. In May 2017, the company completed a similar $1.4 billion transaction with Steward involving 10 facilities.

These and other similar leaseback transactions with Steward, which involved MPT loaning money to Steward for acquisitions, then charging inflated rents, were criticized for inflating MPT's income and executive compensation, while financially encumbering community hospitals.

By 2018, Steward represented 38% of MPT's real estate assets.

MPT entered the Australian healthcare market in 2019 with the purchase of eleven hospitals–seven acute care and four behavioral health–in a leaseback arrangement with Healthscope for $860 million.

Also in 2019, MPT purchased the real estate of fourteen facilities operated by Prospect Medical Holdings. Prospect filed for bankruptcy in January 2025; MPT was alleged to have to contributed to the demise of the company.

2020–present

In 2020, MPT formed a joint venture with executives of Steward and acquired properties from Steward at inflated prices, using funds loaned by MPT.

In March 2022, Medical Properties Trust created a joint venture with Macquarie Group for 50/50 ownership of its portfolio of eight hospitals in Massachusetts, earning MPT $600 million.

In 2023, MPT sold its Australian portfolio to Sydney-based asset management company HMC Capital for $802 million, lower than its purchase price for the facilities.

Steward had financial trouble and by 2023, it was relying on circular funding from MPT to pay its rent obligations. In May 2024, Steward filed for bankruptcy protection. The company accused its founder, Ralph de la Torre and three others — Michael Callum, James Karam, and Sanjay Shetty — of defrauding the company of more than $245 million. As part of the bankruptcy, Steward terminated its master lease and severed its relationship with MPT; MPT leased hospitals formerly operated by Steward to other operators.

In April 2024, the company sold the majority of its interests in five Utah hospitals for $886 million.

From Wikipedia’s article on Medical Properties Trust, shared under CC BY-SA 4.0.7

Leadership

Who has led Medical Properties Trust, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (18)

Subsidiaries and ownership

Subsidiaries (GLEIF)

All 27 subsidiaries (gleif)

Also consolidated

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Timeline

  1. Jun 1, 20268-K Shareholder vote70
  2. Apr 30, 20268-K Results of operations71
  3. Feb 19, 20268-K Results of operations72
  4. Jan 20, 20268-K Regulation FD disclosure; Other events73
  5. Oct 30, 20258-K Results of operations; Other events74
  6. Jul 31, 20258-K Results of operations75
  7. Jun 3, 20258-K Shareholder vote76
  8. May 1, 20258-K Results of operations77
  9. Feb 27, 20258-K Results of operations78
  10. Nov 7, 20248-K Results of operations79
  11. Jun 3, 20248-K Shareholder vote80
  12. May 29, 20248-K Results of operations81
  13. Mar 20, 2023New chief executive Larry H. Portal becomes CEO50
  14. May 26, 2006New chief executive Edward K. Aldag Jr. becomes CEO51
  15. Aug 27, 2003Founded Medical Properties Trust is founded4

Calendar

Coming up

  1. Oct 29, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.13 a share, on Oct 30, 2025.82

When it reported results

  1. Apr 30, 2026Reported quarterly or annual results71
  2. Feb 19, 2026Reported quarterly or annual results72
  3. Oct 30, 2025Reported quarterly or annual results74
  4. Jul 31, 2025Reported quarterly or annual results75
  5. May 1, 2025Reported quarterly or annual results77
  6. Feb 27, 2025Reported quarterly or annual results78
  7. Nov 7, 2024Reported quarterly or annual results79
  8. May 29, 2024Reported quarterly or annual results81

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

312 filings to the SEC since October 2021: 1 quarterly reports, 34 major events, 208 insider forms, 26 large holders, 43 other. The latest 20:

  1. Oct 7, 20264 EDGAR
  2. Oct 7, 20264 EDGAR
  3. Oct 7, 20264 EDGAR
  4. Oct 7, 20264 EDGAR
  5. Oct 7, 20264 EDGAR
  6. Oct 7, 20264 EDGAR
  7. Aug 20, 20264 EDGAR
  8. Aug 6, 2026S-8 EDGAR
  9. Jul 8, 20264 EDGAR
  10. Jul 8, 20264 EDGAR
  11. Jul 8, 20264 EDGAR
  12. Jul 8, 20264 EDGAR
  13. Jul 8, 20264 EDGAR
  14. Jul 8, 20264 EDGAR
  15. Jun 1, 20268-K EDGAR
  16. Apr 30, 20268-K EDGAR
  17. Apr 29, 2026SCHEDULE 13G EDGAR
  18. Apr 13, 2026ARS EDGAR
  19. Apr 13, 2026DEFA14A EDGAR
  20. Apr 13, 2026DEF 14A EDGAR

The 312 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

14 open-market trades by officers, directors and large owners since October 2021: 3 buys and 11 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 20, 2026Hanna James KevinSenior VP, Controller & CAOBuy2,300$4.15$9.5KForm 4
Dec 15, 2025Hooper Rosa HandleySVP of OperationsSale2,000$5.00$10.0KForm 4
Nov 19, 2025Stewart Michael GDirectorSale59,000$5.02$296.2KForm 4
May 5, 2025Stewart Michael GDirectorSale29,000$5.20$150.8KForm 4
Mar 5, 2025Hanna James KevinSenior VP, Controller & CAOBuy7,411$5.75$42.6KForm 4
Dec 26, 2024Hanna James KevinSenior VP, Controller & CAOSale11,641$3.72$43.3KForm 4
Dec 23, 2024Hooper Rosa HandleySVP of OperationsSale3,000$3.67$11.0KForm 4
Oct 9, 2024Stewart Michael GDirectorSale32,780$5.46$179.0KForm 4
Sep 18, 2024Pitman Elizabeth NDirectorBuy8,087$6.01$48.6KForm 4
Aug 27, 2024THOMPSON C REYNOLDS IIIDirectorSale20,530$4.38$89.9KForm 4
Aug 15, 2024Pitman Elizabeth NDirectorSale10,025$4.98$49.9KForm 4
Apr 7, 2022HAMNER R STEVENExecutive Vice President & CFOSale285,000$21.04$6.0MForm 4
Mar 30, 2022Aldag Edward K JRChairman, President & CEOSale615,000$21.33$13.1MForm 4
Mar 10, 2022Stewart Michael GDirectorSale6,000$20.26$121.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Edward K. AldagJr.$1.2M$15.9M91
2025R. Steven Hamner$850.0K$8.2M91
2025Larry H. Portal$685.0K$2.4M91
2025J. Kevin Hanna$535.0K$1.7M91
2025Charles R. Lambert$475.0K$1.3M91
2024ChairmanPresident, and$1.0M$16.4M91
2024DirectorExecutive Vice President$675.0K$8.4M91
2024Senior VicePresident,$643.8K$1.7M91
2024Senior Vice PresidentController$515.0K$1.2M91
2023Chief Executive Officer$1.0M$17.9M91
2023and Chief Financial Officer$675.0K$9.1M91
2023Senior Advisor to the CEO$625.0K$3.5M91
2023and Chief Accounting Officer$500.0K$3.0M91

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.75,253,906$347.7M0.0%−43,975
Vanguard Portfolio Management LLC43,755,548$202.2M0.0%+670,784
State Street Corp25,162,287$118.5M0.0%−398,922
Vanguard Capital Management LLC21,742,204$100.4M0.0%+906,637
Aqr Capital Management LLC17,637,883$81.1M0.0%+6,580,784
Charles Schwab Investment Management Inc11,513,717$53.2M0.0%−467,016
Geode Capital Management, LLC9,953,326$46.0M0.0%−28,596
Wilsey Asset Management Inc7,611,131$35.2M5.2%+262,379
Northern Trust Corp7,410,114$34.2M0.0%+2,189,942
Allianz Asset Management GmbH7,338,412$33.9M0.0%+851,040
Two Sigma Investments, LP7,284,796$33.7M0.0%−1,115,926
Morgan Stanley6,782,715$31.3M0.0%+48,422
Jupiter Asset Management Ltd6,647,786$30.7M0.2%−42,786
Advisors Capital Management, LLC6,598,047$30.5M0.3%+221,697
Bank of New York Mellon Corp6,122,211$28.3M0.0%−190,903
Dimensional Fund Advisors LP5,487,140$25.4M0.0%−1,950,286
Deutsche Bank Ag\5,476,536$25.3M0.0%−132,547
Coatue Management LLC4,525,398$20.9M0.0%No change
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3,539,997$16.4M0.0%+3,538,822
Legal & General Group Plc3,441,629$15.9M0.0%+63,806
Goldman Sachs Group Inc3,195,565$14.8M0.0%+1,288,007
UBS Group AG3,142,032$14.5M0.0%+426,501
Vanguard Fiduciary Trust Co3,090,715$14.3M0.0%+63,816
Principal Financial Group Inc2,365,392$10.9M0.0%−24,962
Bank Of America Corp /de/1,744,452$8.1M0.0%+311,438

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Medical Properties Trust is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMEDICAL PROPERTIES TRUST INC2
  • CIK0001287865
  • Employer ID (EIN)20-019174249
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company49
  • Incorporated inMaryland49
  • Fiscal year endsDecember 312
  • Industry code (SIC)6798 Real Estate Investment Trusts2
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance2
  • Business address10500 Liberty Parkway, Birmingham, AL2
  • Phone205-969-37552
  • Shares outstanding598,100,000 as of May 6, 202647
  • Public float$2.6B as of Jun 30, 202549
  • AuditorPricewaterhouseCoopers LLP, Birmingham, Alabama PCAOB ID 238; it also attests to the company’s internal control over financial reporting49
  • On EDGAR sinceApr 16, 20042
  • Filings1,385 in all: 4 (517), 8-K (264), SC 13G/A (70), 10-Q (64), UPLOAD (50), 4/A (44), 424B5 (42), 5 (38)2
    All 46 form types

    CORRESP (37), 424B2 (23), DEF 14A (22), 10-K (21), 3 (21), DEFA14A (21), SC 13G (19), FWP (17), 10-K/A (10), ARS (10), S-11/A (10), S-3ASR (10), SCHEDULE 13G/A (9), 8-K/A (7), POS AM (7), S-8 (7), 144 (5), EFFECT (5), SC TO-I/A (5), 424B3 (4), SCHEDULE 13G (3), 10-Q/A (2), 3/A (2), PRE 14A (2), S-11 (2), S-3 (2), SC TO-I (2), 424B4 (1), 424B7 (1), 8-A12B (1), CERTNYS (1), NT 10-Q (1), POSASR (1), REGDEX (1), S-3/A (1), S-4 (1), SC 13D (1), SC 13D/A (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2026
    Quarterly report (10-Q) Aug 10, 2026
    Proxy statement (DEF 14A) Apr 13, 2026
    Latest 8-K (8-K) Aug 10, 2026

Securities registered for trading

ClassSymbolExchange
Common stock, par value $0.001 per share, of Medical Properties Trust, Inc.MPTThe New York Stock Exchange

From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).49

Risk factors and legal proceedings

The risks Medical Properties Trust names in Item 1A of its 10-K filed Feb 26, 2026: 52 risks under these headings, as written.49

  • risks related to our business, tenants, and strategy;
  • financing risks;
  • risks relating to real estate investments;
  • risks relating to the healthcare industry;
  • risks relating to our organization and structure; and
  • RISKS RELATED TO OUR BUSINESS, TENANTS, AND STRATEGY
  • Adverse U.S. and global market, economic and political conditions, health crises and other events beyond our control could have a material adverse effect on our business, results of operations, and financial condition.
  • Our revenues are dependent upon our relationships with and success of our tenants, particularly our largest tenants, like Circle, Priory, HSA, Swiss Medical, and Lifepoint Behavioral.
  • We have made investments in certain operators of our healthcare facilities and the cash flows (and related returns) from these investments are subject to more volatility than our properties with traditional net leasing structures.
  • The bankruptcy or insolvency of our tenants or investees could harm our results of operations, financial condition, and liquidity.
  • Declines in the fair value of our assets may force us to recognize impairment charges, which could adversely impact our results of operations, financial condition, liquidity, and the market price of our common stock.
  • It may be costly to replace defaulting tenants or find new tenants when lease terms end, and we may not be able to find replacements on comparable or otherwise suitable terms.
The other 46 risks
  • Our employees are responsible for all aspects of managing our portfolio of over 380 properties across nine countries, and our failure to effectively manage our properties along with any growth may adversely impact our financial condition and cash flows, which could negatively affect our ability to service our debt and make distributions.
  • We have less experience with healthcare facilities located outside the U.S.
  • We and our tenants have exposure to contingent rent escalators, which could impact profitability.
  • Our business is highly competitive, and we may be unable to compete successfully.
  • Many of our tenants have an option to purchase the facilities we lease to them, which could disrupt our operations.
  • Merger and acquisition activity or consolidation in the healthcare industry may result in a change of control of, or a competitor’s investment in, one or more of our tenants or operators, which could have a material adverse effect on us.
  • Our investments in joint ventures could be adversely affected by our lack of control, our partners’ failure to meet their obligations, and disputes with our partners.
  • Increased scrutiny, politicization, and changing expectations from investors, employees, tenants, and other stakeholders regarding corporate responsibility and sustainability matters could adversely impact our reputation, tenant and employee acquisition and retention, and access to capital.
  • FINANCING RISKS
  • Our indebtedness could adversely affect our financial condition, and may otherwise adversely impact our business operations and our ability to make distributions to stockholders.
  • Covenants in our debt instruments limit our operational flexibility, and a breach of these covenants could materially affect our financial condition and results of operations.
  • Failure to hedge effectively against interest rate changes may adversely affect our results of operations and our ability to make distributions to our stockholders.
  • The market price and trading volume of our common stock may be volatile and may decline regardless of our operating performance, and you may lose all or part of your investment.
  • Future sales of common stock may adversely affect our stock price.
  • Downgrades in our credit ratings could have a material adverse effect on our cost and availability of capital.
  • Elevated interest rates may adversely affect the market price of our securities.
  • Limited access to capital may restrict our growth.
  • RISKS RELATING TO REAL ESTATE INVESTMENTS
  • Our investments are, and are expected to continue to be, concentrated in a single industry, making us more vulnerable economically than if our investments were more diversified.
  • The illiquidity of real estate investments could significantly impede our ability to respond to adverse changes in the performance of our facilities and harm our financial condition.
  • Development and construction risks could adversely affect our ability to service our debt and make distributions to our stockholders.
  • We may be subject to risks arising from future acquisitions of real estate.
  • Our facilities may not achieve expected results, which may harm our results of operations and financial condition, as well as our ability to service our debt and make the distributions to our stockholders required to maintain our REIT status.
  • We may suffer losses that are not covered by insurance or that are in excess of our insurance coverage limits.
  • Capital expenditures for facility renovation may be greater than anticipated and may adversely impact rent payments by our tenants and our ability to service our debt and make distributions to our stockholders.
  • Certain of our healthcare facilities are subject to property taxes that may increase in the future and adversely affect our business.
  • As an owner and lessor of real estate, we are subject to risks under applicable environmental laws, the cost of compliance with which and any violation of which could materially adversely affect us.
  • Our interests in facilities through ground leases expose us to the risk of loss of the facility upon breach or termination of the underlying ground lease, may limit our use of the facility, and may result in additional expenses to us if our tenants vacate the facility.
  • RISKS RELATING TO THE HEALTHCARE INDUSTRY
  • The continued pressure on healthcare reimbursement in the U.S. and other countries in which we do business, including shifts from fee-for-service reimbursement towards alternative payment models, other healthcare policy reforms, and government cost cutting measures, could adversely affect the profitability of our tenants and their ability to make payments to us.
  • Significant regulation and loss of licensure or certification or failure to obtain licensure or certification could negatively impact our tenants' financial condition and results of operations and affect their ability to make payments to us.
  • Our tenants are subject to fraud and abuse laws, the violation of which may jeopardize their ability to make payments to us and adversely affect their profitability.
  • Certain of our lease arrangements may be subject to laws related to fraud and abuse or physician self-referrals.
  • We may incur substantial capital expenditures to make our healthcare facilities suitable for tenants or compliant with applicable regulatory requirements.
  • State certificate of need laws may adversely affect our development of facilities and the operations of our tenants.
  • Regulatory restrictions on healthcare transactions involving REITs could adversely affect our business, results of operations, and financial condition.
  • RISKS RELATING TO OUR ORGANIZATION AND STRUCTURE
  • We depend on key personnel, the loss of any one of whom may threaten our ability to operate our business successfully.
  • Pursuant to Maryland law, our charter and bylaws contain provisions that may have the effect of deterring changes in management and third-party acquisition proposals, which in turn could depress the price of our common stock or cause dilution.
  • We rely on information technology in our operations, and any material failure, inadequacy, interruption, or security failure of our technology (or that of our third-party vendors) could harm our business.
  • Unfavorable resolution of pending and future litigation, regulatory proceedings, or governmental inquiries could have a material adverse effect on our and our tenants' business, results of operations, financial condition, and reputation.
  • Changes in accounting pronouncements could adversely affect us and the reported financial performance of our tenants.
  • TAX RISKS
  • Loss of our tax status as a REIT would have significant adverse consequences to us and the value of our common stock.
  • Failure to make required distributions as a REIT would increase our tax burden.
  • Complying with REIT requirements may cause us to forego otherwise attractive opportunities.
  • If certain sale-leaseback transactions are not characterized by the Internal Revenue Service (“IRS”) or similar tax authorities internationally as “true leases,” we may be subject to adverse tax consequences.
  • Transactions with TRSs may be subject to excise tax.
  • Loans to our tenants could be characterized as equity, in which case our income from that tenant might not be qualifying income under the REIT rules and we could lose our REIT status.
  • Certain transfers may generate prohibited transaction income, resulting in a penalty tax on gain attributable to the transaction.
  • Changes in U.S. or foreign tax laws, regulations, including changes to tax rates, may adversely affect our results of operations.

Legal proceedings

We are party to various lawsuits as further described in Note 8 to the consolidated financial statements in Item 8 of this Annual Report on Form 10-K. We have not recorded a liability related to these lawsuits because, at this time, we are unable to determine whether an unfavorable outcome is possible or to estimate reasonably possible losses.

In addition to the foregoing, we are currently and have in the past been subject to various other legal proceedings and regulatory actions in connection with our business. We believe that the resolution of any current pending legal or regulatory matters will not have a material adverse effect on our business, financial condition, results of operations, or cash flows. Nonetheless, we cannot predict the outcome of these proceedings, as legal and regulatory matters are subject to inherent uncertainties, and there exists the possibility that the ultimate resolution of such matters could have a material adverse effect on our financial condition, cash flows, results of operations, and the trading price of our common stock.

The opening of Item 3, Legal Proceedings.49

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91